Terveystalo's maiden results reveal 26% revenue growth and an almost 27% increase in adjusted EBITDA for 2017 - but most of that comes from acquisitions which, along with IPO costs, has halved the company's earnings-per-share and profit for the period. Healthcare Europa looks at the results with an analyst to find out more.